Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.

Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.

Renal fibrosis is the common pathological foundation of many chronic kidney diseases (CKDs). The aim of this study was to investigate whether Hydroxysafflor yellow A (HSYA) can preserve renal function by inhibiting the progression of renal fibrosis and the potential mechanisms.Renal fibrosis was ind...

Full description

Bibliographic Details
Main Authors:	Naping Hu, Jialin Duan, Huihui Li, Yanhua Wang, Fang Wang, Jianjie Chu, Jin Sun, Meiyou Liu, Chao Wang, Chengtao Lu, Aidong Wen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4835075?pdf=render

Similar Items

Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis
by: Jingxue Ye, et al.
Published: (2021-01-01)

Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
by: Lining Jia, et al.
Published: (2015-01-01)

Hydroxysafflor Yellow A Suppresses MRC-5 Cell Activation Induced by TGF-β1 by Blocking TGF-β1 Binding to TβRII
by: Ruiyan Pan, et al.
Published: (2017-05-01)

Hydroxysafflor Yellow A Suppresses Platelet Activating Factor-Induced Activation of Human Small Airway Epithelial Cells
by: Xinjing Guo, et al.
Published: (2018-08-01)

Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
by: Xue Bai, et al.
Published: (2020-09-01)

Establishment of Fluorescence Sensitization Method for Hydroxysafflor Yellow A
by: CAO Haiyan, et al.
Published: (2020-01-01)

Superior Stability of Hydroxysafflor Yellow A in Xuebijing Injection and the Associated Mechanism
by: Weiling Pu, et al.
Published: (2017-12-01)

Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer
by: Na Wu, et al.
Published: (2021-04-01)

Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs
by: Xingtao Wang, et al.
Published: (2016-04-01)

Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits
by: Shan Le-qun, et al.
Published: (2010-08-01)

Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
by: Qin Pan, et al.
Published: (2015-01-01)

Osthole Ameliorates Renal Fibrosis in Mice by Suppressing Fibroblast Activation and Epithelial-Mesenchymal Transition
by: Suping Zhang, et al.
Published: (2018-11-01)

Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation
by: Jingyu Zhang, et al.
Published: (2019-01-01)

Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
by: Lihong Meng, et al.
Published: (2019-01-01)

Biomechanics of TGFβ‐induced epithelial‐mesenchymal transition: implications for fibrosis and cancer
by: Joseph W O’Connor, et al.
Published: (2014-12-01)

The effects of hydroxysafflor yellow A on PPARγ expression in glutamate⁃induced neuron damage
by: Xing⁃miao LIU, et al.
Published: (2012-06-01)

Hydroxysafflor Yellow A Shows Protection against PPARγ Inactivation in Nitrosative Neurons
by: Li Sun, et al.
Published: (2018-01-01)

Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases
by: Hui Ao, et al.
Published: (2018-01-01)

Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
by: Jingxue Ye, et al.
Published: (2020-07-01)

GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition
by: Xiao-Ming Zhou, et al.
Published: (2017-12-01)

Astragaloside and/or Hydroxysafflor Yellow A Attenuates Oxygen-Glucose Deprivation-Induced Cultured Brain Microvessel Endothelial Cell Death through Downregulation of PHLPP-1
by: Jinyi Cao, et al.
Published: (2020-01-01)

Hydroxysafflor Yellow A Attenuates the Apoptosis of Peripheral Blood CD4+ T Lymphocytes in a Murine Model of Sepsis
by: Jinping Wang, et al.
Published: (2017-09-01)

Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
by: Jingxue Ye, et al.
Published: (2021-04-01)

MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells
by: Tang D, et al.
Published: (2021-04-01)

Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production
by: Xin-Tong Wang, et al.
Published: (2021-04-01)

Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury
by: Teng Li, et al.
Published: (2021-01-01)

Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach
by: Cheng Qu, et al.
Published: (2016-11-01)

Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis
by: Si-Qian Gao, et al.
Published: (2018-01-01)

FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial–mesenchymal transition
by: Yanhui Wang, et al.
Published: (2020-08-01)

Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
by: Ila Pant, et al.
Published: (2015-01-01)

Hydroxysafflor Yellow A Inhibits TNF-α-Induced Inflammation of Human Fetal Lung Fibroblasts via NF-κB Signaling Pathway
by: Sen Liu, et al.
Published: (2019-01-01)

Simultaneous Optimization of the Ultrasonic Extraction Method and Determination of the Antioxidant Activities of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B from Safflower Using a Response Surface Methodology
by: Yangyang Zhang, et al.
Published: (2020-03-01)

Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects
by: Feng Zhao, et al.
Published: (2020-12-01)

Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-β Signal Pathway
by: Xianguo Ren, et al.
Published: (2016-01-01)

Hydroxysafflor Yellow A Attenuates Hydrogen Peroxide-Induced Oxidative Damage on Human Umbilical Vein Endothelial Cells
by: Yuefeng Xie, et al.
Published: (2020-01-01)

Hydroxysafflor Yellow A Exerts Anti-Inflammatory Effects Mediated by SIRT1 in Lipopolysaccharide-Induced Microglia Activation
by: Xiude Qin, et al.
Published: (2020-09-01)

Hydroxysafflor Yellow A (HSYA) from Flowers of Carthamus tinctorius L. and Its Vasodilatation Effects on Pulmonary Artery
by: Lijun Wu, et al.
Published: (2012-12-01)

Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis
by: Li Liu, et al.
Published: (2018-01-01)

Hydroxysafflor Yellow A (HSYA) Improves Learning and Memory in Cerebral Ischemia Reperfusion-Injured Rats via Recovering Synaptic Plasticity in the Hippocampus
by: Lu Yu, et al.
Published: (2018-10-01)

Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.
by: Ying Li, et al.
Published: (2013-01-01)